Skip to main content
. 2021 Jul 12;9:686453. doi: 10.3389/fcell.2021.686453

FIGURE 1.

FIGURE 1

MSC-based delivery for cancer treatment. Human MSCs can be utilized to stimulate tumor regression following isolation and modification, acting as a vehicle for the delivery of drugs or molecules into tumors. MSCs, mesenchymal stem/stromal cells; TRAIL/Apo2L, tumor necrosis factor (TNF)-related apoptosis-inducing ligand.